Financials
- Market Capitalization 1.96 B
- Employee 87
- Founded 2018
- CEO N/A
- Website www.tyra.bio
- Headquarter Delaware, United States
- FIGI BBG00RCQD9D1
- Industry Biotechnologie
Gesamtumsatz
Jahresüberschuss
Unverwässertes Ergebnis je Aktie (Unverwässertes EPS)
Gesamtverschuldung
Freier Cashflow
Zahlungsmittel und Zahlungsmitteläquivalente
Related tickers
| # | Name | Preis | 24h % | 7d % | 1M % | 1J % | Marktkapitalisierung | Letzte 7 Tage | |
|---|---|---|---|---|---|---|---|---|---|
| 1992 | GLUE Monte Rosa Therapeutics, Inc. - Common Stock | 23.46 USD | +6.73% | -2.21% | +30.04% | +107.61% | 1.98 B USD | ||
| 1997 | VRDN Viridian Therapeutics, Inc. - Common Stock | 19.08 USD | +0.47% | -5.17% | +17.13% | -15.01% | 1.97 B USD | ||
| 2012 | SION Sionna Therapeutics, Inc. - Common Stock | 42.59 USD | -3.09% | -4.25% | +18.27% | +8.26% | 1.92 B USD | ||
| 2025 | URGN UroGen Pharma Ltd. - Ordinary Shares | 39.19 USD | -0.81% | +4.87% | +27.86% | +106.26% | 1.91 B USD |